REFLEX, a social-cognitive group treatment to improve insight in schizophrenia: study protocol of a multi-center RCT

被引:31
|
作者
Pijnenborg, G. H. M. [1 ,2 ,4 ]
Van der Gaag, Mark [5 ,6 ,7 ]
Bockting, Claudi L. H. [2 ]
Van der Meer, Lisette [3 ,4 ]
Aleman, Andre [2 ,4 ]
机构
[1] GGZ Drenthe, Dept Psychot Disorders, NL-9404 LA Assen, Netherlands
[2] Univ Groningen, Dept Clin Psychol, NL-9712 TS Groningen, Netherlands
[3] Lentis, Ctr Mental Healthcare, Dept Longterm Rehabil, Zuidlaren, Netherlands
[4] Univ Med Ctr Groningen, Neuroimaging Ctr, NL-9700 RB Groningen, Netherlands
[5] Vrije Univ Amsterdam, NL-1081 BT Amsterdam, Netherlands
[6] EMGO Inst Hlth & Care Res, Dept Clin Psychol, NL-1081 BT Amsterdam, Netherlands
[7] Parnassia Psychiat Inst, NL-2512 EX The Hague, Netherlands
来源
BMC PSYCHIATRY | 2011年 / 11卷
关键词
schizophrenia; insight; treatment; self-reflection; self-stigma; perspective-taking; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; BEHAVIORAL THERAPY; INTERNALIZED STIGMA; SELF-REFLECTION; POOR INSIGHT; PSYCHOSIS; ILLNESS; SCALE; INTERVENTION;
D O I
10.1186/1471-244X-11-161
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Insight is impaired in a majority of people with schizophrenia. Impaired insight is associated with poorer outcomes of the disorder. Based on existing literature, we developed a model that explains which processes may possibly play a role in impaired insight. This model was the starting point of the development of REFLEX: a brief psychosocial intervention to improve insight in schizophrenia. REFLEX is a 12-sessions group training, consisting of three modules of four sessions each. Modules in this intervention are: "coping with stigma", "you and your personal narrative", and "you in the present". Methods/Design: REFLEX is currently evaluated in a multicenter randomized controlled trial. Eight mental health institutions in the Netherlands participate in this evaluation. Patients are randomly assigned to either REFLEX or an active control condition, existing of cognitive remediation exercises in a group. In a subgroup of patients, fMRI scans are made before and after training in order to assess potential haemodynamic changes associated with the effects of the training. Discussion: REFLEX is one of the few interventions aiming specifically to improving insight in schizophrenia and has potential value for improving insight. Targeting insight in schizophrenia is a complex task, that comes with several methodological issues. These issues are addressed in the discussion of this paper.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] A multi-center prevalence study and randomized controlled parallel-group pragmatic trial to compare the effectiveness of standardized skin care regimens on skin health in nursing home residents: A study protocol
    Kottner, Jan
    Hahnel, Elisabeth
    Trojahn, Carina
    Stroux, Andrea
    Dobos, Gabor
    Lichterfeld, Andrea
    Richter, Claudia
    Blume-Peytavi, Ulrike
    INTERNATIONAL JOURNAL OF NURSING STUDIES, 2015, 52 (02) : 598 - 604
  • [42] Brief imagery rescripting vs. usual care and treatment advice in refugees with posttraumatic stress disorder: study protocol for a multi-center randomized-controlled trial
    Steil, Regina
    Lechner-Meichsner, Franziska
    Johow, Johannes
    Kruger-Gottschalk, Antje
    Mewes, Ricarda
    Reese, Jens-Peter
    Schumm, Hannah
    Weise, Cornelia
    Morina, Nexhmedin
    Ehring, Thomas
    EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY, 2021, 12 (01)
  • [43] Efficacy and safety of Qi-Jing Hui-Xin Decoction in the treatment of coronary microvascular angina: study protocol for a randomized, controlled, multi-center clinical trial
    Yuanlong Sun
    Chengxin Huang
    Li Huo
    Ying Li
    Jun Chen
    Zixiu Zhang
    Meijun Jia
    Meixian Jiang
    Xiaofen Ruan
    Trials, 22
  • [44] Efficacy and safety of Qi-Jing Hui-Xin Decoction in the treatment of coronary microvascular angina: study protocol for a randomized, controlled, multi-center clinical trial
    Sun, Yuanlong
    Huang, Chengxin
    Huo, Li
    Li, Ying
    Chen, Jun
    Zhang, Zixiu
    Jia, Meijun
    Jiang, Meixian
    Ruan, Xiaofen
    TRIALS, 2021, 22 (01)
  • [45] A multi-center, randomized, 12-month, parallel-group, feasibility study to assess the acceptability and preliminary impact of family navigation plus usual care versus usual care on attrition in managing pediatric obesity: a study protocol
    Ball, Geoff D. C.
    O'Neill, Marcus G.
    Noor, Rafat
    Alberga, Angela
    Azar, Rima
    Buchholz, Annick
    Enright, Michelle
    Geller, Josie
    Ho, Josephine
    Holt, Nicholas L.
    Lebel, Tracy
    Rosychuk, Rhonda J.
    Tarride, Jean-Eric
    Zenlea, Ian
    PILOT AND FEASIBILITY STUDIES, 2023, 9 (01)
  • [46] Clinical Effectiveness of Training for Awareness Resilience and Action Online Compared to Standard Treatment for Adolescents and Young Adults With Depression: Study Protocol and Analysis Plan for a Pragmatic, Multi-Center Randomized Controlled Superiority Trial
    Ekbaeck, Erik
    Granasen, Gabriel
    Svaerling, Rachel
    Blomqvist, Ida
    Henje, Eva
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [47] A Phase II Multi-Center, Non-Randomized, Parallel Group, Non-Inferiority Study to Compare the Efficacy of No Radioactive Iodine Remnant Ablation to Remnant Ablation Treatment in Low- to Intermediate-Risk of Papillary Thyroid Cancer: The MOREthyroid Trial Protocol
    Lee, Eun Kyung
    Lee, You Jin
    Park, Young Joo
    Moon, Jae Hoon
    Yi, Ka Hee
    Kim, Koon Soon
    Lee, Joo Hee
    Cho, Sun Wook
    Joo, Jungnam
    Hwangbo, Yul
    Go, Sujeong
    Park, Do Joon
    ENDOCRINOLOGY AND METABOLISM, 2020, 35 (03) : 571 - 577
  • [48] Efficacy and safety of traditional Chinese medicine external washing in the treatment of postoperative wound of diabetes complicated with anal fistula: Study protocol of a randomized, double-blind, placebo-controlled, multi-center clinical trial
    Kang, Jian
    Liu, Ya
    Peng, Sihan
    Tang, Xiao
    Liu, Lu
    Xie, Ziyan
    He, Yuchi
    Zhang, Xiyu
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [49] A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial
    Shin Takayama
    Takao Namiki
    Takashi Ito
    Ryutaro Arita
    Hajime Nakae
    Seiichi Kobayashi
    Tetsuhiro Yoshino
    Tomoaki Ishigami
    Koichiro Tanaka
    Mosaburo Kainuma
    Kotaro Nochioka
    Airi Takagi
    Masaru Mimura
    Takuhiro Yamaguchi
    Tadashi Ishii
    Trials, 21
  • [50] A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial
    Takayama, Shin
    Namiki, Takao
    Ito, Takashi
    Arita, Ryutaro
    Nakae, Hajime
    Kobayashi, Seiichi
    Yoshino, Tetsuhiro
    Ishigami, Tomoaki
    Tanaka, Koichiro
    Kainuma, Mosaburo
    Nochioka, Kotaro
    Takagi, Airi
    Mimura, Masaru
    Yamaguchi, Takuhiro
    Ishii, Tadashi
    TRIALS, 2020, 21 (01)